169 related articles for article (PubMed ID: 10980994)
21. Lansoprazole, H. pylori, and atrophic gastritis.
Kuipers EJ; Klinkenberg-Knol EC; Festen HP; Meuwissen SG
Gastroenterology; 1997 Dec; 113(6):2018-9. PubMed ID: 9394746
[No Abstract] [Full Text] [Related]
22. Helicobacter pylori eradication in the healing of atrophic gastritis: a one-year prospective study.
Arkkila PE; Seppälä K; Färkkilä MA; Veijola L; Sipponen P
Scand J Gastroenterol; 2006 Jul; 41(7):782-90. PubMed ID: 16785190
[TBL] [Abstract][Full Text] [Related]
23. In patients with Helicobacter pylori gastritis and functional dyspepsia, a biopsy from the incisura angularis provides useful diagnostic information.
Stolte M; Müller H; Talley NJ; O'morain C; Bolling-Sternevald E; Sundin M; Eriksson S; Blum A
Pathol Res Pract; 2006; 202(6):405-13. PubMed ID: 16678357
[TBL] [Abstract][Full Text] [Related]
24. Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection.
Harford W; Lanza F; Arora A; Graham D; Haber M; Weissfeld A; Rose P; Siepman N
Helicobacter; 1996 Dec; 1(4):243-50. PubMed ID: 9398875
[TBL] [Abstract][Full Text] [Related]
25. Atrophy-metaplasia-dysplasia-carcinoma sequence in the stomach: a reality or merely an hypothesis?
Meining A; Morgner A; Miehlke S; Bayerdörffer E; Stolte M
Best Pract Res Clin Gastroenterol; 2001 Dec; 15(6):983-98. PubMed ID: 11866488
[TBL] [Abstract][Full Text] [Related]
26. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
[TBL] [Abstract][Full Text] [Related]
27. Factors influencing Helicobacter pylori eradication with 2 week combination therapy of lansoprazole and amoxycillin: intragastric distribution of colonization and gastric mucosal atrophy.
Saita H; Murakami M; Takahashi Y; Sou Y; Kaitani K; Nishio K; Kita T
J Gastroenterol Hepatol; 1998 Jul; 13(7):725-31. PubMed ID: 9715425
[TBL] [Abstract][Full Text] [Related]
28. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during and after 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer disease.
Meining A; Kiel G; Stolte M
Aliment Pharmacol Ther; 1998 Aug; 12(8):735-40. PubMed ID: 9726386
[TBL] [Abstract][Full Text] [Related]
29. Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: a long-term prospective cohort study.
Toyokawa T; Suwaki K; Miyake Y; Nakatsu M; Ando M
J Gastroenterol Hepatol; 2010 Mar; 25(3):544-7. PubMed ID: 19817964
[TBL] [Abstract][Full Text] [Related]
30. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication.
Kuipers EJ; Lundell L; Klinkenberg-Knol EC; Havu N; Festen HP; Liedman B; Lamers CB; Jansen JB; Dalenback J; Snel P; Nelis GF; Meuwissen SG
N Engl J Med; 1996 Apr; 334(16):1018-22. PubMed ID: 8598839
[TBL] [Abstract][Full Text] [Related]
31. Age-dependent eradication of Helicobacter pylori with dual therapy.
Treiber G; Ammon S; Klotz U
Aliment Pharmacol Ther; 1997 Aug; 11(4):711-8. PubMed ID: 9305480
[TBL] [Abstract][Full Text] [Related]
32. Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole.
Berstad AE; Hatlebakk JG; Maartmann-Moe H; Berstad A; Brandtzaeg P
Gut; 1997 Dec; 41(6):740-7. PubMed ID: 9462205
[TBL] [Abstract][Full Text] [Related]
33. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status.
Sozzi M; Valentini M; Figura N; De Paoli P; Tedeschi RM; Gloghini A; Serraino D; Poletti M; Carbone A
Am J Gastroenterol; 1998 Mar; 93(3):375-9. PubMed ID: 9517643
[TBL] [Abstract][Full Text] [Related]
34. Double gastric infection with Helicobacter pylori and non-Helicobacter pylori bacteria during acid-suppressive therapy: increase of pro-inflammatory cytokines and development of atrophic gastritis.
Sanduleanu S; Jonkers D; De Bruïne A; Hameeteman W; Stockbrügger RW
Aliment Pharmacol Ther; 2001 Aug; 15(8):1163-75. PubMed ID: 11472319
[TBL] [Abstract][Full Text] [Related]
35. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
Howden CW
Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
[TBL] [Abstract][Full Text] [Related]
36. Improvement of long-standing iron-deficiency anemia in adults after eradication of Helicobacter pylori infection.
Sugiyama T; Tsuchida M; Yokota K; Shimodan M; Asaka M
Intern Med; 2002 Jun; 41(6):491-4. PubMed ID: 12135186
[TBL] [Abstract][Full Text] [Related]
37. High-dose proton pump inhibitor plus amoxycillin for the treatment or retreatment of Helicobacter pylori infection.
Malaty H; el-Zimaity HM; Genta RM; Cole RA; Graham DY
Aliment Pharmacol Ther; 1996 Dec; 10(6):1001-4. PubMed ID: 8971301
[TBL] [Abstract][Full Text] [Related]
38. Randomized open trial for comparison of proton pump inhibitors in triple therapy for Helicobacter pylori infection in relation to CYP2C19 genotype.
Inaba T; Mizuno M; Kawai K; Yokota K; Oguma K; Miyoshi M; Take S; Okada H; Tsuji T
J Gastroenterol Hepatol; 2002 Jul; 17(7):748-53. PubMed ID: 12121503
[TBL] [Abstract][Full Text] [Related]
39. Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes.
Nasser SC; Slim M; Nassif JG; Nasser SM
World J Gastroenterol; 2015 Apr; 21(15):4599-606. PubMed ID: 25914469
[TBL] [Abstract][Full Text] [Related]
40. A follow-up study on the effect of Helicobacter pylori eradication on the severity of gastric histology.
Salih BA; Abasiyanik MF; Saribasak H; Huten O; Sander E
Dig Dis Sci; 2005 Aug; 50(8):1517-22. PubMed ID: 16110845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
